OI cohorts from Italy and Sweden were identified solely by Sanger sequencing or Sanger sequencing combined multiplex ligation-dependent probe amplification (MLPA) covering COL1A1/COL1A2 genes. The gene discussed is COL1A2; the disease is osteogenesis imperfecta.